Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between Keytruda and Lynparza

Results for the following 2 drugs:
Keytruda (pembrolizumab)
Lynparza (olaparib)

Interactions between your drugs

There were no interactions found in our database between Keytruda and Lynparza - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Keytruda

A total of 3 drugs (6 brand and generic names) are known to interact with Keytruda.

Lynparza

A total of 404 drugs (1476 brand and generic names) are known to interact with Lynparza.

Drug and food interactions

Major

olaparib food

Applies to: Lynparza (olaparib)

Do not consume grapefruit, grapefruit juice, or Seville oranges during treatment with olaparib. Doing so can significantly increase the blood levels of olaparib and increase the risk and/or severity of side effects such as nausea, vomiting, diarrhea, indigestion, loss of appetite, abdominal pain or discomfort, lung problems, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide